These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2270292)

  • 1. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipyrine biotransformation in the liver of patients with psoriasis].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Bednarowicz G
    Przegl Dermatol; 1988; 75(2):113-6. PubMed ID: 3222456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of disorders of thyroid function on phenazone pharmacokinetics].
    Bolanowski M; Orzechowska-Juzwenko K; Gruszka S; Szymczak J
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):136-9. PubMed ID: 2216953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A; Lowicki Z; Chmara E; Mrozikiewicz A; Baczyk K
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):339-41. PubMed ID: 2235722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].
    Uhlig H; Damrau J; Skölziger R
    Z Gesamte Hyg; 1989 Feb; 35(2):82-4. PubMed ID: 2741499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of antipyrine in viral and alcoholic lesions of the liver].
    Tsyrkunov VM; Bushma MI; Garelik PV; Novitskiĭ GK; Zavodnik LB
    Klin Med (Mosk); 1989 Feb; 67(2):87-9. PubMed ID: 2724896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
    Brockmeyer NH; Frühauf S; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1998 Aug; 3(8):361-6. PubMed ID: 9707517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detoxification function of the liver and body resistance in patients with acute intestinal obstruction].
    Razzakov SM; Krakovskiĭ ME; Ashirmetov AKh
    Khirurgiia (Mosk); 1990 Dec; (12):11-5. PubMed ID: 2079783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The assessment of liver microsomal oxidative capacity via caffeine and antipyrine elimination in patients with chronic active hepatitis: preliminary results].
    Soto Alvarez J; Alsar Ortiz MJ
    An Med Interna; 1992 Nov; 9(11):547-50. PubMed ID: 1467403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenazone pharmacokinetics as an index of hepatic metabolic efficiency.
    Wiela A; Orzechowska-Juzwenko K; Kotlarek-Haus S; Plamieniak B; Wolowiec D
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):562-5. PubMed ID: 3243660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenazone and its value as an indicator of metabolic efficiency of the liver].
    Wiela A; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1987; 41(2):136-51. PubMed ID: 3313327
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of benzonal on the drug-metabolizing function of the liver in pathological states].
    Nadzhimutdinov KN; Khakimov ZZ
    Farmakol Toksikol; 1988; 51(3):72-5. PubMed ID: 3410034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.